{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-017590","form_type":"8-K","ticker":"IMDX","cik":"0001642380","company_name":"Insight Molecular Diagnostics Inc.","filed_at":"2025-07-02T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.546473+00:00","generated_at":"2026-05-18T09:38:34.515734+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Shareholders approve all four proposals at Insight Molecular Diagnostics 2025 annual meeting","bullets":["73.46% quorum achieved; all four director nominees (Riggs, Arno, Last, Silverman) elected.","Ratified CBIZ CPAs P.C. as independent auditor for FY 2025 with 20,986,994 votes for.","Non-binding say-on-pay proposal approved with 18,063,639 votes for.","Amendment to 2018 Equity Incentive Plan approved; shares authorized increased by 1,500,000 to 3,800,000."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-017590","json":"https://secwatch.observer/filing/0001641172-25-017590.json","markdown":"https://secwatch.observer/filing/0001641172-25-017590.md","text":"https://secwatch.observer/filing/0001641172-25-017590.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1642380/000164117225017590/0001641172-25-017590-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1642380/000164117225017590/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T09:38:34.515734+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}